Survodutide: GLP-1/glucagon dual-agonist research overview

Survodutide is a dual agonist at the GLP-1 and glucagon receptors, studied in metabolic research models for the way it engages two pathways at once. This overview is a sourcing and handling reference for HPLC-verified labs.

The dual-agonist mechanism

Single-pathway incretin agonists act at the GLP-1 receptor alone. Survodutide adds glucagon-receptor activity, and the research interest centers on how the balance between the two arms behaves in metabolic models. It sits in the same class discussion as the tri-agonist retatrutide, see our retatrutide pharmacology overview for the multi-receptor context.

Where purity enters

Pure North publishes laboratory reports for the samples and vial sizes listed in Lab Results. Each report identifies its method, reference, area purity and measured content. Open the matching product page to check coverage for the size you select. A report does not cover every size or future lot; contact customer service if your vial reference differs. Bacteriostatic water has no COA.

Handling and storage

Store the lyophilized vial dry at −20 °C. Reconstitute in sterile bacteriostatic water at the working concentration your protocol specifies; our calculator converts vial size and target concentration to an exact diluent volume. Aliquot before freezing and avoid repeated freeze-thaw cycles.

Identity before signal

HPLC area purity and mass-spectrometry identity answer different questions. Check whether each required assay is actually present; the published CPT reports do not include mass-spectrometry identity.

Sourcing in Canada

Canadian-based, shipped domestic via Canada Post Xpresspost, dispatched within 24-48 hours, ~4 days transit, free over $300 CAD, paid by Interac e-Transfer or Bitcoin. Browse the catalog. Supplied as a reference standard for laboratory research use only.